$1.41 3.7%
CMND Stock Price vs. AI Score
Data gathered: October 14

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Clearmind Medicine Common Shares

Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems. The company is headquartered in Vancouver, Canada.


Clearmind Medicine Common Shares
Price $1.41
Target Price Sign up
Volume 325,450
Market Cap $5.5M
Year Range $1.02 - $2.22
Dividend Yield 0%
PE Ratio 0.16
Analyst Rating 0% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24000-2.1M-810,000-0.588
Q2 '24000-910,000-1.7M-0.279
Q1 '24000-1.4M-1.5M-0.901
Q4 '2305,500-5,500-4.1M660,000-11.439
Q3 '2304,000-4,000-3M480,000-2.434

What is the Market Cap of Clearmind Medicine Common Shares?

The Market Cap of Clearmind Medicine Common Shares is $5.5M.

What is Clearmind Medicine Common Shares' PE Ratio?

As of today, Clearmind Medicine Common Shares' PE (Price to Earnings) ratio is 0.16.

What is the current stock price of Clearmind Medicine Common Shares?

Currently, the price of one share of Clearmind Medicine Common Shares stock is $1.41.

How can I analyze the CMND stock price chart for investment decisions?

The CMND stock price chart above provides a comprehensive visual representation of Clearmind Medicine Common Shares' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Clearmind Medicine Common Shares shares. Our platform offers an up-to-date CMND stock price chart, along with technical data analysis and alternative data insights.

Does CMND offer dividends to its shareholders?

As of our latest update, Clearmind Medicine Common Shares (CMND) does not offer dividends to its shareholders. Investors interested in Clearmind Medicine Common Shares should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Clearmind Medicine Common Shares?

Some of the similar stocks of Clearmind Medicine Common Shares are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.